Inspire Medical Systems, Inc. to Present at the BofA Securities 2026 Healthcare Conference
Inspire Medical Systems (NYSE: INSP) will present at the BofA Securities 2026 Healthcare Conference on Wednesday, May 13, 2026 at 11:00 a.m. Eastern Time.
Rhea-AI Summary
Inspire Medical Systems (NYSE: INSP) will present at the BofA Securities 2026 Healthcare Conference on Wednesday, May 13, 2026 at 11:00 a.m. Eastern Time. The presentation will be available via a live webcast and a replay will be accessible in the company's Event Archive for two weeks.
Positive
- None.
Negative
- None.
Details
News Market Reaction – INSP
On Apr 29, the day this news came out, INSP closed 3.08% below the previous close.
Data tracked by StockTitan Argus for the Apr 29 session.
Key Figures
- Conference date
- May 13, 2026
- BofA Securities 2026 Healthcare Conference presentation
- Presentation time
- 11:00 a.m. Eastern Time
- Scheduled start of INSP presentation
- Webcast replay window
- Two weeks
- Replay availability on Investor website Event Archive
- Current share price
- $55.07
- Pre-news market context on April 29, 2026
Historical Context
-
Announced timing and webcast details for Q1 2026 results release.
-
Management presentation at KeyBanc Healthcare Forum with webcast access.
-
Reported strong 4Q25 and FY25 results and revised 2026 revenue guidance.
-
Released preliminary Q4 and FY25 revenue and initial 2026 guidance.
-
Set date and webcast details for 4Q25 and FY25 results release.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
obstructive sleep apnea medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
MINNEAPOLIS, April 29, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities 2026 Healthcare Conference on Wednesday, May 13, 2026.
Inspire is scheduled to present at 11:00 a.m. Eastern Time. The presentation will be accessible via a live webcast here.
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.